![](https://www.microbiometimes.com/wp-content/uploads/2018/06/businesswoman-454874_960_720-326x245.jpg)
Kaleido Biosciences Announces Appointment of Alison Lawton as Chief Executive Officer
Kaleido Biosciences, a clinical-stage healthcare company leading the development of novel chemistries that drive functions of the microbiome organ, today announced that Alison Lawton, Kaleido’s president and chief operating officer (COO), has been appointed to […]